May 06, 2021 / 12:30PM GMT
Operator
Good morning, ladies and gentlemen, and welcome to Chimerix' First Quarter 2021 Earnings Conference Call.
I would now like to introduce you to your host for today's call, Michelle LaSpaluto, Vice President of Strategic Planning and Investor Relations at Chimerix. Please proceed.
Michelle LaSpaluto - Chimerix, Inc. - VP of Strategic Planning & IR
Thank you. Good morning, everyone, and welcome to the Chimerix First Quarter 2021 Financial and Operating Results Conference Call. This morning, we issued a press release which outlines the topics we plan to discuss today. You can access the press release in our Investors section of the website. With me on today's call are President and Chief Executive Officer, Mike Sherman; Chief Medical Officer, Allen Melemed; Chief Financial and Business Officer, Mike Andriole; Chief Scientific Officer, Randall Lanier; and Chief Technology Officer of Imipridones, Josh Allen.
Before we begin, I would like to remind you that the statements made on today's call include forward-looking statements within the meaning
Q1 2021 Chimerix Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
